Reduced DNA methylation at the IL-6 and ERa promoters in PBMCs in RA patients is associated with overexpressed IL-6 and hyperactive ERa signaling (Nile et al., 2008; Liao et al., 2012; Liu et al., 2014). This evidence concerns the gene IL6 and rheumatoid arthritis.